[Late results and prognosis in glomerulonephritis. II. Prognosis in specific forms of glomerulopathies].
Hruby
Z
Z
Katedra i Klinika Nefrologii Akademii Medycznej, Wrocławiu.
D000293:Adolescent; D000328:Adult; D000368:Aged; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D015432:Glomerulonephritis, Membranoproliferative / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D009393:Nephritis / Q000150:complications; D009402:Nephrosis, Lipoid / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D011379:Prognosis; D011507:Proteinuria / Q000150:complications; D012074:Remission Induction; D013290:Streptococcal Infections / Q000150:complications; D013997:Time Factors
D005938:Glucocorticoids
Odległe skutki kłebkowych zapaleń nerek i ich prognozowanie. II. Rokowanie w poszczególnych postaciach glomerulopatii.